Dorsey & Whitney Trust CO LLC Grows Stake in Haleon plc (NYSE:HLN)

Dorsey & Whitney Trust CO LLC raised its stake in Haleon plc (NYSE:HLN) by 14.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,027 shares of the company’s stock after acquiring an additional 3,984 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Haleon were worth $296,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sierra Ocean LLC purchased a new position in Haleon in the fourth quarter valued at about $26,000. Versant Capital Management Inc boosted its stake in Haleon by 2,029.1% in the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after acquiring an additional 3,348 shares during the last quarter. Geneos Wealth Management Inc. purchased a new position in Haleon in the fourth quarter valued at about $35,000. Toronto Dominion Bank boosted its stake in Haleon by 3,470.0% in the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after acquiring an additional 3,470 shares during the last quarter. Finally, Spire Wealth Management purchased a new position in Haleon in the fourth quarter valued at about $39,000. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Stock Performance

Haleon stock opened at $10.38 on Tuesday. The firm’s 50 day simple moving average is $9.68 and its 200 day simple moving average is $9.86. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $46.97 billion, a PE ratio of 30.51, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80.

Haleon (NYSE:HLN) last posted its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, analysts expect that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Increases Dividend

The company also recently announced a — dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This represents a yield of 1.6%. The ex-dividend date is Friday, April 25th. This is a positive change from Haleon’s previous — dividend of $0.05. Haleon’s dividend payout ratio is 58.97%.

Wall Street Analyst Weigh In

A number of analysts recently commented on HLN shares. Hsbc Global Res cut shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. HSBC restated a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Six equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.